The top-selling drugs of 2024 have been identified, with some outlets also looking ahead to the pharmaceutical landscape in 2025. Certain drugs, such as Ozempic and Mounjaro, are reported to be among the top-selling pharmaceuticals in the first half of 2025. The performance of these and other drugs has significant implications for major pharmaceutical companies, with some expecting substantial revenue and others having new products in development.